Literature DB >> 3028964

Bacteriological data on a prospective multicenter study of the effect of two different regimens for selective decontamination in patients with acute leukaemia.

D van der Waaij, W Gaus, D Krieger, G Linzenmeier, M Rozenberg-Arska, H G de Vries-Hospers.   

Abstract

In this paper we described the results of bacteriological monitoring of oropharynx and stool samples from granulocytopenic patients with leukaemia who received oral infection prophylaxis with two different regimens for selective decontamination of the digestive tract. Patients were prospectively randomized either into a group receiving non-absorbable antimicrobial drugs for selective decontamination (polymyxin and neomycin: group A) or into a group receiving polymyxin and co-trimoxazole (group B). The oropharynx was, or became, free of gram-negative bacilli within one week of treatment in 94% and 90%, respectively, of the patients in group A and group B. The stool samples were, or became, negative after the same treatment interval in 91% and 80%, respectively, of the two patient groups. Antibiotic therapy during selective decontamination treatment significantly increased the incidence of positive cultures from the oropharynx and stools. The sensitivity of the gram-negative bacilli isolated during selective decontamination treatment to the drugs administered did not influence the average response to treatment. Both resistant and sensitive gram-negative bacteria appeared to disappear from the patients' samples, mostly within a week, without the need to adjust the selective decontamination treatment. Yeasts behaved in almost the same way as gram-negative bacilli. All patients received oral amphotericin B; some patients occasionally yielded oropharyngeal or faecal cultures which were positive for yeasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028964     DOI: 10.1007/BF01643960

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Effect of systemic antimicrobial prophylaxis on microbial flora.

Authors:  G P Bodey; B Rosenbaum; M Valdivieso; R Bolivar
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

2.  Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

Authors:  C A Kauffman; M K Liepman; A G Bergman; J Mioduszewski
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

3.  Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

Authors:  J C Wade; C A de Jongh; K A Newman; J Crowley; P H Wiernik; S C Schimpff
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

4.  Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.

Authors:  E Kurrle; A W Dekker; W Gaus; E Haralambie; D Krieger; M Rozenberg-Arska; H G de Vries-Hospers; D van der Waaij; F Wendt
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

5.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

  5 in total
  1 in total

1.  Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.

Authors:  W Kern; E Kurrle
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.